{"id":6065,"date":"2023-09-08T17:27:37","date_gmt":"2023-09-08T17:27:37","guid":{"rendered":"https:\/\/cdafound.org\/?page_id=6065"},"modified":"2023-09-08T18:08:56","modified_gmt":"2023-09-08T18:08:56","slug":"global-epidemiology-and-genotype-distribution-of-the-hepatitis-c-virus-infection","status":"publish","type":"page","link":"https:\/\/cdafound.org\/fr\/publications\/global-epidemiology-and-genotype-distribution-of-the-hepatitis-c-virus-infection\/","title":{"rendered":"\u00c9pid\u00e9miologie mondiale et r\u00e9partition des g\u00e9notypes de l\u2019infection par le virus de l\u2019h\u00e9patite C"},"content":{"rendered":"<figure class=\"wp-block-image alignleft size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"153\" height=\"204\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2023\/09\/image.jpeg\" alt=\"\" class=\"wp-image-6066\" srcset=\"https:\/\/cdafound.org\/wp-content\/uploads\/2023\/09\/image.jpeg 153w, https:\/\/cdafound.org\/wp-content\/uploads\/2023\/09\/image-9x12.jpeg 9w\" sizes=\"auto, (max-width: 153px) 100vw, 153px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25086286\">Gower E, Estes C, Blach S et al. \u00c9pid\u00e9miologie mondiale et distribution g\u00e9notypique de l&#039;infection par le virus de l&#039;h\u00e9patite C. Journal of Hepatology 2014; 61: S45-S57.<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Le traitement de l&#039;infection chronique par le virus de l&#039;h\u00e9patite C (VHC) a le potentiel de changer consid\u00e9rablement au cours des prochaines ann\u00e9es \u00e0 mesure que les sch\u00e9mas th\u00e9rapeutiques \u00e9voluent rapidement. Cependant, le fardeau de l&#039;infection chronique n&#039;a pas \u00e9t\u00e9 quantifi\u00e9 au niveau mondial \u00e0 l&#039;aide des donn\u00e9es les plus r\u00e9centes. Des estimations mises \u00e0 jour de la pr\u00e9valence, de la vir\u00e9mie et des g\u00e9notypes du VHC sont essentielles pour l&#039;\u00e9laboration de strat\u00e9gies de gestion ou d&#039;\u00e9limination de l&#039;infection par le VHC. Pour y parvenir, une recherche documentaire compl\u00e8te a \u00e9t\u00e9 men\u00e9e sur la pr\u00e9valence anti-VHC, la pr\u00e9valence vir\u00e9mique et les g\u00e9notypes pour tous les pays. Les \u00e9tudes ont \u00e9t\u00e9 incluses en fonction de leur capacit\u00e9 \u00e0 \u00eatre extrapol\u00e9es \u00e0 la population g\u00e9n\u00e9rale, \u00e0 la taille de l&#039;\u00e9chantillon et \u00e0 l&#039;\u00e2ge de l&#039;\u00e9tude. Les estimations nationales disponibles ont \u00e9t\u00e9 utilis\u00e9es pour \u00e9laborer des estimations r\u00e9gionales et mondiales. Quatre-vingt-sept pays ont signal\u00e9 une pr\u00e9valence anti-VHC, tandis que les taux vir\u00e9miques du VHC \u00e9taient disponibles pour 54 pays. Le nombre total d&#039;infections vir\u00e9miques mondiales par le VHC a \u00e9t\u00e9 estim\u00e9 \u00e0 80 (64\u2013103) millions d&#039;infections. La distribution des g\u00e9notypes \u00e9tait disponible pour quatre-vingt-dix-huit pays. \u00c0 l&#039;\u00e9chelle mondiale, le g\u00e9notype 1 (G1) \u00e9tait le plus courant (46%), suivi de G3 (22%), G2 (13%) et G4 (13%). En conclusion, le nombre total d&#039;infections au VHC rapport\u00e9es ici est inf\u00e9rieur aux estimations pr\u00e9c\u00e9dentes. L&#039;exclusion des donn\u00e9es d&#039;\u00e9tudes ant\u00e9rieures men\u00e9es au plus fort de l&#039;\u00e9pid\u00e9mie de VHC, ainsi que les ajustements pour r\u00e9duire la pr\u00e9valence chez les enfants, sont probablement des facteurs contributifs. Les r\u00e9sultats soulignent la n\u00e9cessit\u00e9 d&#039;\u00e9tudes de surveillance plus robustes pour quantifier plus pr\u00e9cis\u00e9ment la charge de morbidit\u00e9 du VHC.<\/p>","protected":false},"excerpt":{"rendered":"<p>Gower E, Estes C, Blach S, et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. Journal of Hepatology 2014; 61: S45-S57. The treatment of chronic hepatitis C virus (HCV) infection has the potential to change significantly over the next few years as therapeutic regimens are rapidly evolving. However, the burden of [&hellip;]<\/p>\n","protected":false},"author":939,"featured_media":0,"parent":2705,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"subtheme":[],"class_list":["post-6065","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/pages\/6065","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/users\/939"}],"replies":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/comments?post=6065"}],"version-history":[{"count":2,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/pages\/6065\/revisions"}],"predecessor-version":[{"id":6070,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/pages\/6065\/revisions\/6070"}],"up":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/pages\/2705"}],"wp:attachment":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/media?parent=6065"}],"wp:term":[{"taxonomy":"subtheme","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/subtheme?post=6065"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}